[1]
Bibi N, Parveen Z, Nawaz MS, Kamal MA. In silico structure modeling and molecular docking analysis of phosphoribosyl pyrophosphate amidotransferase (PPAT) with antifolate inhibitors. Curr Cancer Drug Targets 2019; 19(5): 408-16.
[http://dx.doi.org/10.2174/1568009619666181127115015]
[http://dx.doi.org/10.2174/1568009619666181127115015]
[2]
Peluso I, Palmery M, Yarla NS, Perry G, Kamal MA. From oxidative stress to ageing via lifestyle, nutraceuticals, polypharmacy, and neuropsychological factors. Oxid Med Cell Longev 2018; 20186352689
[3]
Alexiou A, Soursou G, Chatzichronis S, et al. Role of GTPases in the regulation of mitochondrial dynamics in Alzheimer’s disease and CNS-related disorders. Mol Neurobiol 2019; 56(6): 4530-8.
[4]
Wei W, Ahmad SS, Chi S, Xie Y, Kamal MA, Li J. From molecular mechanism to the etiology of sjogren syndrome. Curr Pharm Des 2018; 24(35): 4177-85.
[5]
Sheikh IA, Jiffri EH, Ashraf GM, Kamal MA. Structural insights into the camel milk lactoperoxidase: homology modeling and molecular dynamics simulation studies. J Mol Graph Model 2019; 86: 43-51.
[6]
Lakkakula BVKS, Farran B, Lakkakula S, et al. Small molecule tyrosine kinase inhibitors and pancreatic cancer-trials and troubles. Semin Cancer Biol 2019; 56: 149-67.
[7]
Sharma AK, Sharma VR, Gupta GK, Ashraf GM, Kamal MA. Advanced glycation end products (AGEs), glutathione and breast cancer: Factors, mechanism and therapeutic interventions. Curr Drug Metab 2018.
[8]
Sheikh IA, Yasir M, Khan I, et al. Lactoperoxidase immobilization on silver nanoparticles enhances its antimicrobial activity. J Dairy Res 2018; 85(4): 460-4.
[9]
Islam MT, Ali ES, Uddin SJ, et al. Phytol: a review of biomedical activities. Food Chem Toxicol 2018; 121: 82-94.
[10]
Jabir NR, Firoz CK, Bhushan A, Tabrez S, Kamal MA. The use of azoles containing natural products in cancer prevention and treatment: an overview. Anticancer Agents Med Chem 2018; 18(1): 6-14.
[11]
Rizvi SMD, Hussain T, Ahmed ABF, et al. Gold nanoparticles: a plausible tool to combat neurological bacterial infections in humans. Biomed Pharmacother 2018; 107: 7-18.
[12]
Sharma M, Pandey C, Sharma N, Kamal MA, Sayeed U, Akhtar S. Cancer nanotechnology - an excursion on drug delivery systems. Anticancer Agents Med Chem 2018; 18(15): 2078-92.
[13]
Sheikh IA, Jiffri EH, Ashraf GM, Kamal MA, Beg MA. Structural studies on inhibitory mechanisms of antibiotic, corticosteroid and catecholamine molecules on lactoperoxidase. Life Sci 2018; 207: 412-9.
[14]
Sharma N, Sharma M, Shakeel E, et al. Molecular interaction and computational analytical studies of pinocembrin for its antiangiogenic potential targeting VEGFR-2: a persuader of metastasis. Med Chem 2018; 14(6): 626-40.
[15]
Khan H. Marya, Amin S, Kamal MA, Patel S. Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects. Biomed Pharmacother 2018; 101: 860-70.
[16]
Miya Shaik M, Tamargo IA, Abubakar MB, Kamal MA, Greig NH, Gan SH. The Role of microRNAs in Alzheimer’s disease and their therapeutic potentials. Genes 2018; 9(4): 174.
[17]
Azhar A, Ashraf GM, Zia Q, et al. Frontier view on nanotechnological strategies for neuro-therapy. Curr Drug Metab 2018; 19(7): 596-604.
[18]
Islam A, Kamal MA. Editorial: Current vision of systemic autoimmune diseases - from diagnosis to management. Endocr Metab Immune Disord Drug Targets 2018; 18(2): 96-7.
[19]
Khan H, Zafar M, Den-Haan H, Perez-Sanchez H, Kamal MA. In-silico studies of isolated phytoalkaloid against lipoxygenase: study based on possible correlation. Comb Chem High Throughput Screen 2018; 21(3): 215-21.
[20]
Khan H, Jawad M, Kamal MA, et al. Evidence and prospective of plant derived flavonoids as antiplatelet agents: strong candidates to be drugs of future. Food Chem Toxicol 2018; 119: 355-67.
[21]
Reale M, D’Angelo C, Costantini E, et al. Expression profiling of cytokine, cholinergic markers, and Amyloid-β deposition in the APPSWE/PS1dE9 mouse model of Alzheimer’s disease pathology. J Alzheimers Dis 2018; 62(1): 467-76.
[22]
Ahmad F, Siddiqui A, Kamal MA, Sohrab SS. Inhibition of neurogenesis by zika virus infection. CNS Neurol Disord Drug Targets 2018; 17(2): 78-86.
[23]
Islam MT, Ali ES, Uddin SJ, et al. Sousa JM, de Moura Dantas SMM, Rolim HML, de Carvalho Melo-Cavalcante AA, Mubarak MS, Yarla NS, Shilpi JA, Mishra SK, Atanasov AG, Kamal MA. Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer. Cancer Lett 2018; 420: 129-45.
[24]
Islam MA, Khandker SS, Alam F, Kamal MA, Gan SH. Genetic risk factors in thrombotic primary antiphospholipid syndrome: a systematic review with bioinformatic analyses. Autoimmun Rev 2018; 17(3): 226-43.
[25]
Iman K, Mirza MU, Mazhar N, Vanmeert M, Irshad I, Kamal MA. In silico structure-based identification of novel acetylcholinesterase inhibitors against Alzheimer’s disease. CNS Neurol Disord Drug Target 2018; 17(1): 54-68.
[26]
Khan H, Rengasamy KRR, Pervaiz A, Nabavi SM, Atanasov AG, Kamal MA. Plant-derived mPGES-1 inhibitors or suppressors: a new emerging trend in the search for small molecules to combat inflammation. Eur J Med Chem 2018; 153: 2-28.
Related Journals
Current Drug Safety
Current Neuropharmacology
Current Pharmaceutical Design
Current Neurovascular Research
Current Pharmaceutical Analysis
Central Nervous System Agents in Medicinal Chemistry
Current Vascular Pharmacology
Current Alzheimer Research
Current Molecular Pharmacology
Current Aging Science
Related Books
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
New Findings from Natural Substances
Pharmaceutical Chemistry and Production: An Introductory Textbook
Evidence-Based Research in Ayurveda against COVID-19 in Compliance with Standardized Protocols and Practices
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Pharmaceuticals for Targeting Coronaviruses
Medical Applications of Beta-Glucan
Nanotechnology Driven Herbal Medicine for Burns: From Concept to Application
Frontiers in Clinical Drug Research-Dementia
Article Metrics
7